Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Prime Global UCITS ETF Acc

F50A · IE0009DRDY20 · class UCITS ETF Acc · USD · domicile Ireland
Equity · Global · Mid capSFDR art. 6
Index tracked: Solactive GBS Developed Markets Large & Mid Cap USD Index NTR
TER
0.05%+ trans. 0.01%
Fund size
3.2 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 21 Nov 2024 · costs from the KID as of 2 Sept 2026 · 1,364 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of the Solactive GBS Developed Markets Large & Mid Cap USD Index Net TR (the "Index"). The anticipated level of the tracking error, under normal market conditions is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the index constituents are included in the Index return. The Index is an equity index representative of the large and mid-cap markets across 23 developed countries, covering…

Performance since series start (in euro) — base 100

13 Nov 20248 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2025202612785125
High 127 (13 Aug 2026) · low 85 (8 Apr 2025) · last 125. Past performance is not indicative of future results.

Returns in euro

1 year+21.2%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+24.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.52%11.52%
Max drawdown−8.87%−8.87%
Sharpe1.421.42
Sortino2.122.12
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · F50A · IE0009DRDY201
RebalixF50A · IE0009DRDY20 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+21.83%+21.62%+0.21%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 1,364 securities · top-10 weight = 27.1%
Top holdingsWeight
NVIDIA CORP5.6%
APPLE INC5.1%
MICROSOFT CORP4.1%
AMAZON.COM INC2.7%
ALPHABET INC CL A2.2%
BROADCOM INC1.9%
ALPHABET INC CL C1.9%
META PLATFORMS INC-CLASS A1.4%
TESLA INC1.2%
MICRON TECHNOLOGY INC1.2%
Countries (% of fund)
United States71.0%Japan6.8%Canada3.5%United Kingdom3.5%Germany2.1%
Sectors (% of fund)
Information Technology30.0%Financials16.6%Industrials10.7%Health Care9.3%Consumer Discretionary8.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
F50A · Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/IE0009DRDY20/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/IE0009DRDY20/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/IE0009DRDY20/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/IE0009DRDY20
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · F50A · IE0009DRDY202